跳至主要内容
临床试验/EUCTR2004-004404-21-GB
EUCTR2004-004404-21-GB进行中(未招募)1 期

Omega-3-Polyunsaturated Fatty Acids and Atherosclerosis in Systemic Lupus Erythematosus: Cellular Mechanisms and Functional Consequences - Fish oils in Lupus

GreenPark Healthcare Trust0 个研究点目标入组 60 人开始时间: 2005年2月17日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients fulfilling ACR classification criteria for SLE
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years)
  • F.1.3.1 Number of subjects for this age range

排除标准

  • diabetes mellitus (fasting blood glucose >7.8mmol/l); hypertension of systolic >160mmHg or diastolic >90mmHg (as determined by the mean of three readings taken on the first visit); carcinoma (other than superficial skin carcinoma); significant pulmonary, hepatic or renal disease; typical angina or myocardial infarction; active infectious diseases; use of antihypertensive, oral hypoglycaemic or lipid lowering agent (in the last 3 months); cyclophosphamide therapy (due to potential to interfere with acetlycholinesterase); glucocorticoids equivalent to greater than 10mg prednisolone. All pregnant or lactating women will be excluded

研究者

发起方
GreenPark Healthcare Trust

相似试验